British Columbia is home to one of Canada’s most advanced and fastest‑growing life sciences sectors, British Columbia stands as one of North America’s most compelling destinations for life sciences innovation, offering a powerful combination of world‑class research, rapid sector growth, and a highly collaborative environment. With over 2,000 companies, 20,000+ skilled professionals, and more than $2.5 billion in annual economic impact, BC delivers the scale and momentum global investors look for. The province is internationally recognized for breakthroughs in immunotherapy, oncology, infectious disease, and precision health, supported by leading institutions such as UBC and BC Cancer. The number of life sciences businesses grew by 26.5% between 2018 and 2021, reflecting strong commercialization pipelines and a deep pool of scientific talent. BC’s expanding biomanufacturing capacity, advanced research infrastructure, and fast‑growing AI‑enabled digital health ecosystem position the province as a gateway to global markets and a premier partner for innovation. With a strategic Pacific Rim location and a government committed to accelerating growth, British Columbia offers one of the most competitive, future‑ready environments for companies and investors shaping the next generation of health technologies. We are pleased to introduce Integrated Nanotherapeutics and Eyam Health, both recently selected for KGAP+ and eager to explore partnership and collaboration opportunities in Japan. They are highly motivated to build strong relationships within the Japanese ecosystem.
We look forward to meeting you at WHX Osaka.